SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008448
Filing Date
2019-05-13
Accepted
2019-05-13 17:05:33
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_adialpharma.htm 10-Q 421179
2 CERTIFICATION f10q0319ex31-1_adialpharma.htm EX-31.1 17295
3 CERTIFICATION f10q0319ex31-2_adialpharma.htm EX-31.2 17052
4 CERTIFICATION f10q0319ex32-1_adialpharma.htm EX-32.1 5973
5 CERTIFICATION f10q0319ex32-2_adialpharma.htm EX-32.2 6466
6 GRAPHIC img_001.jpg GRAPHIC 113992
  Complete submission text file 0001213900-19-008448.txt   3376237

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adil-20190331.xml EX-101.INS 430670
8 XBRL SCHEMA FILE adil-20190331.xsd EX-101.SCH 50401
9 XBRL CALCULATION FILE adil-20190331_cal.xml EX-101.CAL 34954
10 XBRL DEFINITION FILE adil-20190331_def.xml EX-101.DEF 214007
11 XBRL LABEL FILE adil-20190331_lab.xml EX-101.LAB 355774
12 XBRL PRESENTATION FILE adil-20190331_pre.xml EX-101.PRE 285886
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 19819246
SIC: 2834 Pharmaceutical Preparations